Efficacy and tolerability of BacoMind® on memory improvement in elderly participants - A double blind placebo controlled study

Journal of Pharmacology and Toxicology

Volumn 3, Issue 6, 2008, Pages 425-434

  Barbhaiya, Harshad C ^a   Desai, Rajeshwari P ^a   Saxena, Vinod S ^b   Pravina, K ^b   Wasim, P ^b   Geetharani, P ^b   Allan, J Joshua ^b   Venkateshwarlu, K ^b   Amit, A ^b  

^a Natural Remedies Pvt Ltd ^*

^b Natural Remedies Pvt Ltd   (India)

Author keywords

BacoMind ; Bacopa monnieri; Efficacy; Elderly participants; Memory; Tolerability

Indexed keywords

BACOPA MONNIERI EXTRACT; PLACEBO;

ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; ATTENTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; ELDERLY CARE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MENTAL FUNCTION; MENTAL PERFORMANCE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; RANDOMIZED CONTROLLED TRIAL; RECALL; SINGLE DRUG DOSE; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; VERBAL MEMORY;

EID: 63249098562     PISSN: 1816496X     EISSN: None     Source Type: Journal    
DOI: 10.3923/jpt.2008.425.434     Document Type: Article

References (36)

1. Abhang, R., 1993. Study to evaluate the effect of a micro (suksma) medicine derived from Brahmi (Herpestris monierra) on students of average intelligence. J. Res. Ayur. Siddha., 14: 10-24.
2. Bhattacharya, S.K., A. Kumar and S. Ghosal, 1999. Effect of Bacopa monniera on animal models of Alzhieimer's disease and perturbed central cholinergic markers of cognition in rats. Res. Commun. Pharmacol. Toxicol., 4: II1-II12.
3. Bhattacharya, S.K., A. Bhattacharya, A. Kumar and S. Ghosal, 2000. Antioxidant activity of Bacopa monniera in rat frontal cortex, striatum and hippocampus. Phytother. Res., 14: 174-179.
4. Conkiln, H.M., C.E. Curtis, J. Katsanis and W.G. Lacono, 2000. Verbal working memory impairment in schizophrenia patients and their first-degree relatives: Evidence from the digit span task. Am. J. Psychiatry., 157: 275-277.
5. Cullum, C.M., N. Butters, A.I. Troster and D.P. Salmon, 1990. Normal aging and forgetting rates on the Wechsler Memory Scale-Revised. Arch. Clin. Neuropsychol., 5: 23-30.
6. Deepak, M. and A. Amit, 2004. The need for establishing indentities of bacoside A and B, the putative major bioactive saponins of Indian medicimal plant Bacopa monnieri Phytomedicine, 11: 264-268.
7. Deepak, M., G.K. Sangli, P.C. Arun and A. Amit, 2005. Quantitative determination of the major saponin mixture bacoside A in Bacopa monnieri by HPLC. Phytochem. Anat., 16: 24-20.
8. Dipanwita, D.D., P. Kapoor, R.P. Dighe, R. Padmaja and M.S. Anand et al., 2008. In vitro safety evaluation and anticlastogenic effect of BacoMind™ on human lymphocytes. Biomed. Environ. Sci., 21: 7-23.
9. Fann J. R., J. M. Uomoto and W. J. Katon, 2001. Cognitive improvement with treatment of depression following mild traumatic brain injury. Psychosomatics, 42: 48-54.
10. Hróbjartsson, A., 1996. The uncontrollable placebo effect. Eur. J. Clin. Pharmacol., 50: 345-348.
11. Joshua, A.J., A. Damodaran, N.S. Deshmukh, K.S Gondar and A. Amit, 2007. Safety evaluation of a standardized phytochemical composition extracted from Bacopa monnieri in Sprague-Dawley rats. Food Chem. Toxicol., 45: 1928-1937.
12. Kasture, S.B., V.S. Kasture, A.J. Joshua, A. Damodaran and A. Amit, 2007. Nootropic activity of BacoMind™, an efifiched phytochemical composition from Bacopa monniera. J. Nat. Rem., 7: 150-157.
13. Kemeny, V., S. Molnar, M. Andrejkovics, A. Makai and L. Csiba, 2005. Acute and chronic effects of Vinpocetine on cerebral haemodynamics and neuropsycological performance in multi-infarct patients. J. Clin. Pharmacol., 45: 1048-1054.
14. Lyons, W.L., C. B. Johnston, K. E. Covinsky and N. M. Resnick, 2001. Geriatric Medicine. In: Current Medical Diagnosis and Treatment. Tierney, L.M. Jr, S.J. McPhee and M.A. Papadakis (Eds.). Lange Medical Books/McGraw-Hill, New York, ISBN: 0-07-116332-8, pp: 51.
15. Mattos, P., V. Lino, L. Rizo, A. Alfano, C. Araujo and R. Raggio, 2003. Memory complaints and test performance in healthy elderly persons. Arq. Neuropsiquiatr., 61: 920-924.
16. Mukherjee, P.K., V. Kumar and P.J. Houghton, 2007. Screening of Indian medicinal plants for acetylcholinesterase inhibitory activity. Phytother. Res., 21: 1142-1145.
17. Pravina, K., K.R. Ravindra, K.S. Gouddr, D.R. Vinod and A.J. Joshua et al., 2007. Safety evaluation of BacoMind™ in healthy volunteers: A phase I study. Phytomedicine, 14: 301-308.
18. Purdon, S.E., B.D.W. Jones, E. Stip, A. Labelle and D. Addington et al., 2001. Neuropsychological change in early phase schizophrenia during 12 months of treatment with Olanzapine, Rispendone, or Haloperidol. Arch. Gen. Psychiatry, 57: 249-258.
19. Rey, A., 1964. Clinical Examination in Psychology. Paris, France: Presses Universitaires de France
20. Rich, J.B., E. Svoboda and G.G. Brown, 2005. Diazepam-induced prospective memory impairment and its relation to retrospective memory, attention and arousal. Hum. Psychopharmacol. Clin. Exp., 21: 101-108.
21. Roodenrys, S., D. Booth, S. Bulzomi, A. Phipps, C. Micallef and J. Smoker, 2002. Chronic effects of Brahmi (Bacopa monnieri) on human memory. Neuropsycopharmacology, 27: 279-281.
22. Russo, A., F. Borrelli, A. Campisi, R. Acquaviva, G. Raciti and A. Vanella, 2003a. Nitric oxide-related toxicity in cultured astrocytes: Effect of Bacopa monniera. Life Sci., 73: 1517-1526.
23. Russo, A., A.A. Izzo, F. Borrelli, M. Renis and A. Vanella, 2003b. Free radical scavenging capacity and protective effect of Bacopa monniera L. on DNA damage. Phytother. Res., 17: 870-875.
24. Russo, A. and F. Borrelli, 2005. Bacopa monniera a reputed nootropic plant: An overview. Phytomedicine, 12: 305-317.
25. Sharma, R., C. Chaturvedi and P.V. Tewari, 1987. Efficacy of Bacopa monnieri in revitalizing intellectual functions in children. J. Res. Educ. Indian Med., 6: 1-10.
26. Silver, H., P. Feldman, W. Bilker and R.C. Gur, 2003. Working memory deficit as a core neuropsycological dysfunction in schizophrenia. Am. J. Psychiatry, 160: 1809-1816.
27. Singh, H.K., R.P. Rastogi, Srimal and B.N. Dhawan, 1988. Effect of bacoside A and B on avoidance responses in rats. Phytother. Res., 2: 70-75.
28. Singh, H.K. and B.N. Dhawan, 1992. Drugs Affecting Learning and Memory. In: Lectures in Neurobiology, Tandon, P.N., V. Bijlani and S. Wadhava (Eds.). Wiley Eastern, New Delhi, pp: 189-207.
29. Singh, H.K. and B.N. Dhawan, 1997. Neuropsychopharmacological effects of the Ayurvedic nootropic Bacopa monniera Linn. (Brahmi). Indian J. Pharmacol., 29: S359-S365.
30. Small, G.W., 2002. What we need to know about age related memory loss. BMJ., 324: 1502-1505.
31. Spiers, P.A., D. Myers, G.S. Hochanadel, H.R. Lieberman and R.J. Wurtman, 1996. Citicoline improves verbal memory in aging. Arch. Neurol., 53: 441-448.
32. Stough, C., J. Lloyd, J. Clarke, L.A. Downey, C.W. Hutchison, T. Rodgers and P.J. Nathan, 2001. The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology, 156: 481-484.
33. Tan, R.S., S.J. Pu and J.W. Culberson, 2004. Role of androgens in mild cognitive impairment and possible interventions during andropause. Med. Hypotheses, 62: 14-18.
34. Usha, P.D., P. Wasim, J.A. Joshua, P. Geetharini and B. Murali et al., 2008. BacoMind®: A cognitive enhancer in children requiring individual education programme. J. Pharmacol. Toxicol., 3: 302-310.
35. Vohora, D., S.N. Pal and K.K. Pillai, 2000. Protection from phenytoin-induced cognitive deficit by Bacopa monniera a reputed Indian nootropic plant. J. Ethnopharmacol., 71: 383-390.
36. Walach, H., C. Sadaghiani, C. Dehm and D. Bierman, 2005. The therapeutic effect of clinical trials: Understanding placebo response rates in clinical trials-A secondary analysis. BMC Med. Res. Methodol., 5: 26-26.